Notice of Update to PAR-18-007, "Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)"

Notice Number: NOT-HL-18-618

Key Dates
Release Date: April 9, 2018

Related Announcements
PAR-18-007
NOT-OD-17-062

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that the NHLBI Center for Translation Research and Implementation Science, is participating in PAR-18-007, "Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)." The following changes have been made to reflect NHLBI's participation in this FOA:

Part 1. Overview Information

Catalog of Federal Domestic Assistance (CFDA) Number(s)

The following CFDA number has been added to the FOA:

93.840

Section VII. Agency Contacts

Scientific/Research Contact(s)

The following contact has been added to the FOA:

Cheryl Boyce, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-496-1051
Email: cheryl.boyce@nih.gov

Inquiries

Please direct all inquiries to: